G protein-coupled receptor kinases and hypertension: A review of disease mechanisms

High Blood Pressure and Cardiovascular Prevention

Volumn 13, Issue 4, 2006, Pages 151-158

  Iaccarino, Guido ^a,b   Campanile, Alfonso ^a   Santulli, Gaetano ^a   Zuppieri, Francesco ^a   Koch, Walter J ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR KINASE; G PROTEIN COUPLED RECEPTOR KINASE 2; G PROTEIN COUPLED RECEPTOR KINASE 5; G PROTEIN COUPLED RECEPTOR KINASE 6;

ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MEDICAL RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 33846312846     PISSN: 11209879     EISSN: None     Source Type: Journal    
DOI: 10.2165/00151642-200613040-00002     Document Type: Review

References (80)

1. Lefkowitz RJ. G protein-coupled receptor kinases. Cell 1993 Aug 13; 74 (3): 409-12
2. Premont RT, Inglese J, Lefkowitz RJ. Protein kinases that phosphorylate activated G protein-coupled receptors. Faseb J 1995 Feb; 9 (2): 175-82
3. Wess J. Molecular basis of receptor/G-protein-coupling selectivity. Pharmacol Ther 1998 Dec; 80 (3): 231-64
4. Vroon A, Kavelaars A, Limmroth V, et al. G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Immunol 2005 Apr 1; 174 (7): 4400-6
5. Kavelaars A, Vroon A, Raatgever RP, et al. Increased acute inflammation, leukotriene B4-induced chemotaxis, and signaling in mice deficient for G protein-coupled receptor kinase 6. J Immunol 2003 Dec 1; 171 (11): 6128-34
6. Shichi H, Somers RL. Light-dependent phosphorylation of rhodopsin: purification and properties of rhodopsin kinase. J Biol Chem 1978 Oct 10; 253 (19): 7040-6
7. Hisatomi O, Matsuda S, Satoh T, et al. A novel subtype of G-protein-coupled receptor kinase, GRK7, in teleost cone photoreceptors. FEBS Lett 1998 Mar 13; 424 (3): 159-64
8. Premont RT, Macrae AD, Stoffel RH, et al. Characterization of the G protein-coupled receptor kinase GRK4: identification of four splice variants. J Biol Chem 1996 Mar 15; 271 (11): 6403-10
9. Benovic JL, Gomez J. Molecular cloning and expression of GRK6: a new member of the G protein-coupled receptor kinase family. J Biol Chem 1993 Sep 15; 268 (26): 19521-7
10. Moepps B, Vatter P, Frodl R, et al. Alternative splicing produces transcripts encoding four variants of mouse G-protein-coupled receptor kinase 6. Genomics 1999 Sep 1; 60 (2): 199-209
11. Parmentier M, Libert F, Schurmans S, et al. Expression of members of the putative olfactory receptor gene family in mammalian germ cells. Nature 1992 Jan 30; 355 (6359): 453-5
12. Weiss ER, Ducceschi MH, Horner TJ, et al. Species-specific differences in expression of G-protein-coupled receptor kinase (GRK) 7 and GRK1 in mammalian cone photoreceptor cells: implications for cone cell phototransduction. J Neurosci 2001 Dec 1; 21 (23): 9175-84
13. Inglese J, Freedman NJ, Koch WJ, et al. Structure and mechanism of the G protein-coupled receptor kinases. J Biol Chem 1993 Nov 15; 268 (32): 23735-8
14. Palczewski K, Buczylko J, Lebioda L, et al. Identification of the N-terminal region in rhodopsin kinase involved in its interaction with rhodopsin. J Biol Chem 1993 Mar 15; 268 (8): 6004-13
15. Lodowski DT, Pitcher JA, Capel WD, et al. Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma. Science 2003 May 23; 300 (5623): 1256-62
16. Lodowski DT, Tesmer VM, Benovic JL, et al. The structure of G protein-coupled receptor kinase (GRK)-6 defines a second lineage of GRKs. J Biol Chem 2006 Jun 16; 281 (24): 16785-93
17. Vatter P, Stoesser C, Samel I, et al. The variable C-terminal extension of G-protein-coupled receptor kinase 6 constitutes an accessorial autoregulatory domain. Febs J 2005 Dec; 272 (23): 6039-51
18. Penn RB, Pronin AN, Benovic JL. Regulation of G protein-coupled receptor kinases. Trends Cardiovasc Med 2000 Feb; 10 (2): 81-9
19. Stoffel RH, Randall RR, Premont RT, et al. Palmitoylation of G protein-coupled receptor kinase, GRK6: lipid modification diversity in the GRK family. J Biol Chem 1994 Nov 11; 269 (45): 27791-4
20. Koch WJ, Inglese J, Stone WC, et al. The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase. J Biol Chem 1993 Apr 15; 268 (11): 8256-60
21. Lodowski DT, Barnhill JF, Pyskadlo RM, et al. The role of G beta gamma and domain interfaces in the activation of G protein-coupled receptor kinase 2. Biochemistry 2005 May 10; 44 (18): 6958-70
22. Pitcher JA, Inglese J, Higgins JB, et al. Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors. Science 1992 Aug 28; 257 (5074): 1264-7
23. Touhara K, Inglese J, Pitcher JA, et al. Binding of G protein beta gamma-subunits to pleckstrin homology domains. J Biol Chem 1994 Apr 8; 269 (14): 10217-20
24. Kunapuli P, Gurevich VV, Benovic JL. Phospholipid-stimulated autophosphorylation activates the G protein-coupled receptor kinase GRK5. J Biol Chem 1994 Apr 8; 269 (14): 10209-12
25. Onorato JJ, Gillis ME, Liu Y, et al. The beta-adrenergic receptor kinase (GRK2) is regulated by phospholipids. J Biol Chem 1995 Sep 8; 270 (36): 21346-53
26. Rapacciuolo A, Suvarna S, Barki-Harrington L, et al. Protein kinase A and G protein-coupled receptor kinase phosphorylation mediates beta-1 adrenergic receptor endocytosis through different pathways. J Biol Chem 2003 Sep 12; 278 (37): 35403-11
27. Pronin AN, Benovic JL. Regulation of the G protein-coupled receptor kinase GRK5 by protein kinase C. J Biol Chem 1997 Feb 7; 272 (6): 3806-12
28. Shenoy SK, Lefkowitz RJ. Receptor regulation: beta-arrestin moves up a notch. Nat Cell Biol 2005 Dec; 7 (12): 1159-61
29. Brown NG, Fowles C, Sharma R, et al. Mechanistic studies on rhodopsin kinase: light-dependent phosphorylation of C-terminal peptides of rhodopsin. Eur J Biochem 1993 Mar 15; 212 (3): 840
30. Cong M, Perry SJ, Lin FT, et al. Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79. J Biol Chem 2001 May 4; 276 (18): 15192-9
31. Winstel R, Freund S, Krasel C, et al. Protein kinase cross-talk: membrane targeting of the beta-adrenergic receptor kinase by protein kinase C. Proc Natl Acad Sci U S A 1996 Mar 5; 93 (5): 2105-9
32. Braz JC, Gregory K, Pathak A, et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 2004 Mar; 10 (3): 248-54
33. Daaka Y, Pitcher JA, Richardson M, et al. Receptor and G betagamma isoform-specific interactions with G protein-coupled receptor kinases. Proc Natl Acad Sci U S A 1997 Mar 18; 94 (6): 2180-5
34. Touhara K, Koch WJ, Hawes BE, et al. Mutational analysis of the pleckstrin homology domain of the beta-adrenergic receptor kinase: differential effects on G beta gamma and phosphatidylinositol 4,5-bisphosphate binding. J Biol Chem 1995 Jul 14; 270 (28): 17000-5
35. DebBurman SK, Ptasienski J, Benovic JL, et al. G protein-coupled receptor kinase GRK2 is a phospholipid-dependent enzyme that can be conditionally activated by G protein betagamma subunits. J Biol Chem 1996 Sep 13; 271 (37): 22552-62
36. Freeman JL, Pitcher JA, Li X, et al. α-Actinin is a potent regulator of G protein-coupled receptor kinase activity and substrate specificity in vitro. FEBS Lett 2000 May 19; 473 (3): 280-4
37. Pitcher JA, Tesmer JJ, Freeman JL, et al. Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases. J Biol Chem 1999 Dec 3; 274 (49): 34531-4
38. Elorza A, Sarnago S, Mayor Jr F. Agonist-dependent modulation of G protein-coupled receptor kinase 2 by mitogen-activated protein kinases. Mol Pharmacol 2000 Apr; 57 (4): 778-83
39. Sarnago S, Elorza A, Mayor Jr F. Agonist-dependent phosphorylation of the G protein-coupled receptor kinase 2 (GRK2) by Src tyrosine kinase. J Biol Chem 1999 Nov 26; 274 (48): 34411-6
40. Lorenz K, Lohse MJ, Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 2003 Dec 4; 426 (6966): 574-9
41. Chuang TT, Paolucci L, De Blasi A. Inhibition of G protein-coupled receptor kinase subtypes by Ca2+/calmodulin. J Biol Chem 1996 Nov 8; 271 (45): 28691-6
42. Chen CK, Inglese J, Lefkowitz RJ, et al. Ca(2+)-dependent interaction of recoverin with rhodopsin kinase. J Biol Chem 1995 Jul 28; 270 (30): 18060-6
43. Iaccarino G, Cipolletta E, Fiorillo A, et al. Beta(2)-adrenergic receptor gene delivery to the endothelium corrects impaired adrenergic vasorelaxation in hypertension. Circulation 2002 Jul 16; 106 (3): 349-55
44. Feldman RD. Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. J Clin Invest 1990 Mar; 85 (3): 647-52
45. Feldman RD, Gros R. Impaired vasodilator function in hypertension: the role of alterations in receptor-G protein coupling. Trends Cardiovasc Med 1998 Oct; 8 (7): 297-305
46. Lembo G, Iaccarino G, Vecchione C, et al. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm. J Clin Invest 1997 Oct 15; 100 (8): 2007-14
47. Gros R, Benovic JL, Tan CM, et al. G-protein-coupled receptor kinase activity is increased in hypertension. J Clin Invest 1997 May 1; 99 (9): 2087-93
48. Gros R, Tan CM, Chorazyczewski J, et al. G-protein-coupled receptor kinase expression in hypertension. Clin Pharmacol Ther 1999 May; 65 (5): 545-51
49. Gros R, Chorazyczewski J, Meek MD, et al. G-protein-coupled receptor kinase activity in hypertension: increased vascular and lymphocyte G-protein receptor kinase-2 protein expression. Hypertension 2000 Jan; 35 (1 Pt 1): 38-42
50. Ishizaka N, Alexander RW, Laursen JB, et al. G protein-coupled receptor kinase 5 in cultured vascular smooth muscle cells and rat aorta: regulation by angiotensin II and hypertension. J Biol Chem 1997 272: 32483-32488
51. Eckhart AD, Ozaki T, Tevaearai H, et al. Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure. Mol Pharmacol 2002 Apr; 61 (4): 749-58
52. Keys JR, Zhou RH, Harris DM, et al. Vascular smooth muscle overexpression of G protein-coupled receptor kinase 5 elevates blood pressure, which segregates with sex and is dependent on Gi-mediated signaling. Circulation 2005; 112: 1145-53
53. Leosco D, Iaccarino G, Cipolletta E, et al. Exercise restores beta-adrenergic vasorelaxation in aged rat carotid arteries. Am J Physiol Heart Circ Physiol 2003 Jul; 285 (1): H369-74
54. Guyton AC, Coleman TG, Young DB, et al. Salt balance and long-term blood pressure control. Annu Rev Med 1980; 31: 15-27
55. Jose PA, Eisner GM, Felder RA. Renal dopamine receptors in health and hypertension. Pharmacol Ther 1998 Nov; 80 (2): 149-82
56. Felder RA, Sanada H, Xu J, et al. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A 2002 Mar 19; 99 (6): 3872-7
57. Casari G, Barlassina C, Cusi D, et al. Association of the alpha-adducin locus with essential hypertension. Hypertension 1995 Mar; 25 (3): 320-6
58. Speirs HJ, Katyk K, Kumar NN, et al. Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens 2004 May; 22 (5): 931-6
59. Liu S, Premont RT, Kontos CD, et al. A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nat Med 2005 Sep; 11 (9): 952-8
60. Koch WJ, Rockman HA, Samama P, et al. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science 1885; 268: 1350-3
61. Choi DJ, Koch WJ, Hunter JJ, et al. Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase. J Biol Chem 1997 Jul 4; 272 (27): 17223-9
62. Manning BS, Shotwell K, Mao L, et al. Physiological induction of a β-adrenergic receptor kinase inhibitor transgene preserves β-adrenergic responsiveness in pressure-overload cardiac hypertrophy. Circulation 2000 Nov 28; 102 (22): 2751-7
63. Tachibana H, Naga Prasad SV, Lefkowitz RJ, et al. Level of βARK1 inhibition determines the degree of cardiac dysfunction following chronic pressure overload induced heart failure. Circulation 2005; 111: 591-7
64. Anderson KM, Eckhart AD, Willette RN, et al. The myocardial β-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats. Hypertension 1999; 33: 402-7
65. Eckhart AD, Koch WJ. Expression of a beta-adrenergic receptor kinase inhibitor reverses dysfunction in failing cardiomyocytes. Mol Ther 2002 Jan; 5 (1): 74-9
66. Park SJ, Choi DJ, Kim CW. Hypertensive left ventricular hypertrophy: relation to beta-adrenergic receptor kinase-1 (βARK1) in peripheral lymphocytes. J Hypertens 2004 May; 22 (5): 1025-32
67. Iaccarino G, Tomhave ED, Lefkowitz RJ, et al. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. Circulation 1998 Oct 27; 98 (17): 1783-9
68. Ungerer M, Bohm M, Elce JS, et al. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 1993 Feb; 87 (2): 454-63
69. Hata JA, William ML, Koch WJ. Genetic manipulation of myocardial β-adrenergic receptor activation and desensitization. J Mol Cell Cardiol 2004; 37: 11-21
70. Brodde OE. Beta-adrenoceptors in cardiac disease. Pharmac Ther 1993; 60: 405-30
71. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, et al. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 1997 Jan 7; 95 (1): 169-75
72. Iaccarino G, Barbato E, Cipolleta E, et al. Cardiac betaARK1 upregulation induced by chronic salt deprivation in rats. Hypertension 2001 Aug; 38 (2): 255-60
73. Rockman HA, Chien KR, Choi DJ, et al. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci U S A 1998 Jun 9; 95 (12): 7000-5
74. Dorn II GW, Tepe NM, Wu G, et al. Mechanisms of impaired beta-adrenergic receptor signaling in G(αq)-mediated cardiac hypertrophy and ventricular dysfunction. Mol Pharmacol 2000 Feb; 57 (2): 278-87
75. Dzimiri N, Basco C, Moorji A, et al. Characterization of lymphocyte beta 2-adrenoceptor signalling in patients with left ventricular volume overload disease. Clin Exp Pharmacol Physiol 2002 Mar; 29 (3): 181-8
76. Dzimiri N, Muiya P, Andres E, et al. Differential functional expression of human myocardial G protein receptor kinases in left ventricular cardiac diseases. Eur J Pharmacol 2004 Apr 12; 489 (3): 167-77
77. Leineweber K, Rohe P, Beilfuss A, et al. G-protein-coupled receptor kinase activity in human heart failure: effects of beta-adrenoceptor blockade. Cardiovasc Res 2005 Jun 1; 66 (3): 512-9
78. Williams ML, Koch WJ. Viral-based myocardial gene therapy approaches to alter cardiac function. Annu Rev Physiol 2004; 66: 49-75
79. Iaccarino G, Barbato E, Cipolletta E, et al. Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur Heart J 2005 Sep; 26 (17): 1752-8
80. Hata JA, Williams ML, Schroder JN, et al. Lymphocyte levels of GRK2 (βARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved β-adrenergic signaling after mechanical unloading. J Card Fail 2006; 12: 360-8